ARCADIA EVIDENCE
Design stronger networks with confidence
Protocol support
Protocol-defined study populations with continuous data collection and an unbroken audit trail through submission.
External control arms
Constructed from regulatory-ready, de-identified longitudinal records
Feasibility and cohort discovery
Natural-language cohort discovery and feasibility counts
Fit-for-purpose regulatory-ready datasets
Therapeutic-area-specific, not a generic export
Effectiveness studies
Comparative effectiveness and HEOR analyses run directly on the RWD asset.
Full reproducibility manifests
Documented, auditable data lineage supporting FDA submissions and sponsor programs.
Driving Outcomes through Activation
source-to-output data lineage
median longitudinal patient history
patients with at least one EHR event and one claims event
What Sets Our Evidence Apart
Built on embedded clinical access
Generated from data captured inside the health system, not licensed or reconstructed after the fact.
Reproducible by design
Every study ships with a documented audit trail and reproducibility manifest.
Fit-for-purpose, not generic
TA-specific datasets built for the study, with clinician-in-the-loop validation.
Evidence that feeds action
Findings connect directly into Arcadia’s provider activation layer, not a one-time report.
